OptiBiotix Health Plc (AIM:OPTI)
London · Delayed Price · Currency is GBP · Price in GBX 5.61
+0.01 (0.20%)
Jul 24, 2026, 3:30 PM GMT
OptiBiotix Health Revenue
In the year 2025, OptiBiotix Health had annual revenue of 1.17M GBP with 34.02% growth. OptiBiotix Health had revenue of 609.00K in the half year ending December 31, 2025, with 107.85% growth.
Revenue
1.17M
Revenue Growth
+34.02%
P/S Ratio
4.96
Revenue / Employee
129.56K
Employees
9
Market Cap
5.78M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.17M | 296.00K | 34.02% |
| Dec 31, 2024 | 870.00K | 226.00K | 35.09% |
| Dec 31, 2023 | 644.00K | 187.00K | 40.92% |
| Dec 31, 2022 | 457.00K | -1.76M | -79.35% |
| Dec 31, 2021 | 2.21M | 689.75K | 45.28% |
| Dec 31, 2020 | 1.52M | 778.36K | 104.49% |
| Dec 31, 2019 | 744.88K | 230.59K | 44.84% |
| Nov 30, 2018 | 514.29K | 323.22K | 169.16% |
| Nov 30, 2017 | 191.07K | -97.05K | -33.68% |
| Nov 30, 2016 | 288.12K | 259.92K | 921.70% |
| Nov 30, 2015 | 28.20K | - | - |
| Nov 30, 2014 | - | - | - |
| Jul 31, 2012 | - | - | - |
| Jul 31, 2010 | - | - | - |
| Jul 31, 2009 | - | - | - |
| Jul 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Palatin Technologies | 9.76M |
| Futura Medical | 1.70M |
| Fusion Antibodies | 1.60M |
| Oxford BioDynamics | 1.20M |
| Physiomics | 1.01M |
| Genflow Biosciences | 585.61K |
| CRISM Therapeutics | 231.00K |
| Thalia Therapeutics | 7.26K |